Patent ID: 8552042

Claim:
A method of treating a Candida mycosis further defined as vulvovaginal candidiasis and/or oropharyngeal candidiasis (oral thrush) comprising: obtaining a combination drug comprising an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor, wherein the epithelial cell or endothelial cell adhesion inhibitor is Ilaprost, Cicaprost, Ticlopidine, or Clopidogrel; and topically treating mucosa of a subject having a Candida mycosis further defined as vulvovaginal candidiasis and/or oropharyngeal candidiasis with the combination drug, wherein the epithelial cell or endothelial cell adhesion inhibitor is applied to the mucosa in an amount that is between ⅕ to 1/100 of the epithelial cell or endothelial cell adhesion inhibitor's maximum daily systemic dose.